{
    "eid": "2-s2.0-85105468274",
    "title": "Acute leucoencephalomyelopathy and quadriparesis after CAR T-cell therapy",
    "cover-date": "2021-05-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Hematology",
            "@code": "2720",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [],
    "authors": [
        "Ranjit Nair",
        "Ga\u00eblle Drillet",
        "Faustine Lhomme",
        "Anthony Le Bras",
        "Laure Michel",
        "John Rossi",
        "Marika Sherman",
        "Allen Xue",
        "Anne Kerber",
        "Nutchawan Jittapiromsak",
        "Linda Chi",
        "Sudhakar Tummala",
        "Sattva S. Neelapu",
        "Roch Houot"
    ],
    "citedby-count": 10,
    "ref-count": 10,
    "ref-list": [
        "Chimeric antigen receptor T-cell therapy - assessment and management of toxicities",
        "ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells",
        "Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial",
        "Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma",
        "Current concepts in the diagnosis and management of cytokine release syndrome",
        "Endothelial activation and blood-brain barrier disruption in neurotoxicity after adoptive immunotherapy with CD19 CAR-T cells",
        "Clinical and biological correlates of neurotoxicity associated with CAR T-cell therapy in patients with B-cell acute lymphoblastic leukemia",
        "T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial",
        "Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells",
        "GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts"
    ],
    "affiliation": [
        {
            "affiliation-city": "Rennes",
            "@id": "60028893",
            "affilname": "Centre Hospitalier Universitaire de Rennes",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028893",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "Houston",
            "@id": "60015023",
            "affilname": "The University of Texas MD Anderson Cancer Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015023",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Santa Monica",
            "@id": "120143212",
            "affilname": "a Gilead Company",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/120143212",
            "affiliation-country": "United States"
        }
    ],
    "funding": []
}